Question 1

Is Toviaz 4 Mg Prolonged-Release Tablets (Fesoterodine Fumarate) currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Toviaz 4 Mg Prolonged-Release Tablets (Fesoterodine Fumarate) has 2 active shortage notices across 1 country (Ireland). Status is refreshed daily from official regulatory sources.

Question 2

Why is Toviaz 4 Mg Prolonged-Release Tablets (Fesoterodine Fumarate) in shortage?

Accepted Answer

Regulators attribute the current Toviaz 4 Mg Prolonged-Release Tablets (Fesoterodine Fumarate) shortages to supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Toviaz 4 Mg Prolonged-Release Tablets (Fesoterodine Fumarate) shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 4 Dec 2026 to 16 Dec 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Toviaz 4 Mg Prolonged-Release Tablets (Fesoterodine Fumarate) shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.

Toviaz 4 Mg Prolonged-Release Tablets (Fesoterodine Fumarate) shortage status

Where Toviaz 4 Mg Prolonged-Release Tablets (Fesoterodine Fumarate) is in shortage

Why Toviaz 4 Mg Prolonged-Release Tablets (Fesoterodine Fumarate) is in shortage

Frequently asked questions

Get alerted when Toviaz 4 Mg Prolonged-Release Tablets (Fesoterodine Fumarate) status changes